
The discovery around how supportive tissue cells of light-sensing photoreceptor cells convert vitamin A for vision could inform potential treatments for vision disorders associated with mutations in the RPE65 gene.
A study, led by the National Eye Institute’s (NEI) Laboratory of Retinal Cell and Molecular Biology, uncovered the mystery behind how a previously uncharacterized region of protein RPE65 binds with retinal pigment epithelium (RPE) cells’ membrane by becoming a spiral shape in order to enter the membrane and complete the vitamin A conversion process that restores the photoreceptors sensitivity to light in the eye.
Dr Sheetal Uppal, research fellow at NEI and the study’s first author, said: ‘Our findings solve a long-standing puzzle in RPE65’s structure, clarifying its function, while expanding our knowledge of membrane-binding in a way that we hope will inform disease models in more accurate ways.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here